Ascletis Pharma CEO on IPO Performance, New Drugs, Revenue Targets

The following video is brought to you courtesy of the Bloomberg Markets and Finance YouTube Channel. Click the video below to watch it now.

Jan.17 — Jason Wu, chairman and chief executive officer at Ascletis Pharma, discusses the company’s performance since the IPO, their new drugs coming to market, competition in the industry, regulatory approvals, drug prices, revenue targets and what drugs he’s most excited about. He speaks on “Bloomberg Markets: Asia.”

Recommended Viewing


You'll LOVE these Conservative Tees & Gear!

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE

VIEW HERE



Comments are closed.